Friday 6-20-2014 Achillion Pharmaceuticals (ACHN) $ACHN

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
Friday 6-20-2014 Achillion Pharmaceuticals (ACHN) $ACHN opened at 8.42 hitting the high price of 8.61 and a day low of 7.97 with a total volume of 28,475,776. ACHN had a previous close of 8.08 and has been seeing an average volume of 14,422,670.

Overall Average: 96% Buy

Recent stock forum discussions about ACHN http://investorshangout.com/search?q=ACHN&...mp;yt0=Go!

Achillion
at Investor's Business Daily - Fri Jun 20, 5:38PM CDT
Achillion (ACHN) shares rose 0.6% to 8.13 after R. W. Baird noted that Merck's (MRK) official tender offer indicated that there was another bidder for Idenix Pharmaceuticals, which means that a company is still looking for a nucleoside hepatitis C... (full story)

Achillion Could Win Idenix's Mystery Suitor: Analyst
at Investor's Business Daily - Fri Jun 20, 11:44AM CDT
Hot biotech stock Achillion Pharmaceuticals (ACHN) was up 2%, near 8.20, in midday trading in the stock market today after an analyst found more support for its prospects as a buyout candidate. R. W. Baird's Brian Skorney noted that Merck's (MRK)... (full story)

The Zacks Analyst Blog Highlights: Idenix, Achillion Pharmaceuticals, Nektar, Orexigen, Celgene, Alexion and Biogen
PR Newswire - Thu Jun 19, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Idenix (Nasdaq:IDIX-Free Report), Achillion Pharmaceuticals (Nasdaq:ACHN-Free Report), Nektar (Nasdaq:NKTR-Free Report), Orexigen (Nasdaq:OREX-Free Report), Celgene (Nasdaq:CELG-Free Report), Alexion (Nasdaq:ALXN-Free Report) and Biogen (Nasdaq:BIIB-Free Report). (full story)

Biotech Stock Roundup: HCV Back in Focus - Idenix, Achillion Soar - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Jun 18, 9:33AM CDT
It was about hepatitis C cirus (HCV) treatments and companies last week with the Merck-Idenix acquisition announcement grabbing eyeballs. (full story)

Nasdaq stocks posting largest volume increases
AP - Tue Jun 17, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading: (full story)

Nasdaq stocks posting largest percentage increases
AP - Tue Jun 17, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading: (full story)

Most active Nasdaq-traded stocks
AP - Tue Jun 17, 5:03PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading: (full story)

Critical Alerts For Bank of America, Achillion Pharmaceuticals, Walmart, SunEdison, and Advanced Micro Devices Released By InvestorsObserver
PR Newswire - Tue Jun 17, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for BAC, ACHN, WMT, SUNE, and AMD. (full story)

Achillion Gets Massive Price Target Hike On HCV Drugs
at Investor's Business Daily - Mon Jun 16, 10:18PM CDT
Biotech Achillion Pharmaceuticals (ACHN) got another boost Monday when Maxim Group more than tripled its price target on the stock, sending shares up 21% on the stock market today. After having dinner with company executives, analyst Jason Kolbert... (full story)

Achillion gets price target hike
at Investor's Business Daily - Mon Jun 16, 5:56PM CDT
The biotech company's shares soared 20.9% to 7.82 after Maxim Group more than tripled its price target on Achillion Pharmaceuticals (ACHN) stock. Analyst Jason Kolbert increased his target to 22 from 6 on the potential of hepatitis C drug candidates,... (full story)

Why Fusion-io, Achillion Pharmaceuticals, and Covidien Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Mon Jun 16, 4:15PM CDT
Following the first down week for the broad-based S&P 500  in quite some time investors were looking for something positive to start their work week, and a bevy of economic data gave them what they were looking for. Industrial production... (full story)

Why Achillion Pharmaceuticals (ACHN) Is Spiking Today
at The Street - Mon Jun 16, 9:33AM CDT
Achillion Pharmaceuticals (ACHN) is rocketing up after having its price target raised significantly to $22 from $6 by analysts at Maxim. (full story)

3 Stocks That Soared Stupendously This Week
Keith Speights, The Motley Fool - Motley Fool - Sun Jun 15, 8:15AM CDT
How would you like a 40% gain in one week? How about gains of over 120% -- or more than 220%? Shareholders of three health-care stocks don't have to wonder how they'd like those types of returns. They experienced the joy first-hand. One of this... (full story)

This Week in Biotech: Actions Speak Louder Than Words
Sean Williams, The Motley Fool - Motley Fool - Sat Jun 14, 10:20AM CDT
With the  SPDR S&P Biotech Index  up  39% over the trailing 12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and... (full story)

Today's Top Biotech Stocks to Watch: Achillion Pharmaceuticals, Nektar Therapeutics and Progenics Ph
George Budwell, The Motley Fool - Motley Fool - Fri Jun 13, 8:02AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for  Achillion Pharmaceuticals   ,  Nektar Therapeutics    and  Progenics Pharmaceuticals   .  Achillion falling back down to Earth Shares of hepatitis C... (full story)

Alexion Pharmaceuticals Inc. (ALXN) Stock Research Links

ALXN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Papa John's Faces Investor Lawsuit: Class Action Looms

Updated Category News Views 0

Papa John's in Hot Water Again? Look, just when you think the pizza game is all dough and cheesy goodness, along comes a legal scuffle to toss our assumptions. Bronstein, Gewirtz & Grossman, LLC has slapped a class action lawsuit against Papa John's International, Inc. (NASDAQ: PZZA), claiming the company and some of its higher-ups haven't been playing fair with the...

Continue Reading
Michigan Roof Inspections: Seasonal Insights That Count

Updated Category News Views 2

Weather's Wrath and the Michigan Roof Here's the deal: Michigan doesn't mess around when it comes to weather. We're talking harsh winters with piles of snow, followed by muggy summers that toss storms like they're confetti. Keeping that roof in top shape isn't just some luxury; it’s a downright necessity. Gut-punch reality? Many ignore it until it's too late. That's...

Continue Reading
AXIS-Y: Global Expansion Fueled by KRW 430B Valuation

Updated Category News Views 3

Rewriting the Playbook in Global Skincare AXIS-Y decided to do things their way, not just because they could afford to, but because they believed in their vision. Their strategy defies the trends-driven tactics of this cutthroat beauty world. Instead, they’ve been all about climate-inspired products and vegan, cruelty-free standards. And now, after notching up some...

Continue Reading
Nutromics Welcomes Plaxco: Strategic Tech Leap Forward

Updated Category News Views 3

Professor Plaxco’s Dynamic Role at Nutromics Some folks start their day with breakfast and coffee, but Nutromics is grabbing headlines by introducing Professor Kevin Plaxco as the new Chief Scientific Officer. This strategic shift, made public on September 7, 2026, signals Nutromics’ ambition to amplify its DNA-based sensing footprint. As they gear up to launch their...

Continue Reading
Coastal Property Realities: A Deep Dive into Ownership

Updated Category News Views 2

Buying Coastal Property: A Balancing Act Ah, the dream of owning a piece of the beach in sunny South Florida. It sounds glamorous—something to brag about at the next family gathering. But let me tell you, diving into coastal property ownership isn't just about sipping cocktails by the ocean. It's about handling a fair share of headaches most folks don't anticipate....

Continue Reading
NeuralTrust Expands to London as AI Risks Intensify

Updated Category News Views 4

NeuralTrust's Strategic London Expansion In a world where AI agents are sprinting ahead of our security instincts, NeuralTrust makes a big play in the UK market, locking in their position with a new London office. This move isn't just about expansion—it's about tackling the tide of challenges head-on that comes with putting AI agents into the wild. London: A Hub for...

Continue Reading
Early Orders Key for Custom Kids' Gifts This Season

Updated Category News Views 1

Unwrap the Secret to Perfect Holiday Presents When it comes to giving the little ones something special for the holidays, the trick lies in timing. Not your run-of-the-mill timing, mind you—I'm talking about understanding how handcrafted, personalized toys can make or break the season. If you've ever scrambled for a last-minute gift, you know how that shaky feeling sets...

Continue Reading
Stem Cell Market Set for Major Gains to 2031

Updated Category News Views 1

Stem Cells: The Next Frontier or Hype? Folks, stem cells are no longer just a sci-fi concept tucked away in lab coats. This sector's set to boom from USD 18.9 billion in 2026 to a whopping USD 32.57 billion by 2031. Yeah, you heard it right, a solid 11.5% compound annual growth rate. Now, whether you're an investor or just keeping your finger on the biotech pulse, there's...

Continue Reading
Ekinops and 1&1 Versatel Fuel a Connectivity Revolution

Updated Category News Views 1

A European Partnership for Modern Connectivity Big players in the telecom industry are joining forces, and it's like watching a seasoned boxer find his perfect sparring partner. Today, Ekinops, a heavyweight in European connectivity, is shaking hands with 1&1 Versatel, a lead puncher in Germany's B2B communications. They're rolling out a unified connectivity portfolio...

Continue Reading
DoorDash Speeds Up Gifting: Same-Day Delivery Wins

Updated Category News Views 1

Transforming Urgent Gift-Giving with Local Delivery Ever found yourself scrambling for a last-minute gift when time seems to be slipping away? That's where DoorDash steps up, changing the game with their same-day delivery options. In the fast-paced world we're living in, folks aren't just leaning on DoorDash for takeout anymore. They're pushing it as a lifeline for...

Continue Reading

Top 5 Most Recently Viewed Articles

Regeneron Advances Libtayo® for Treating Squamous Cell Carcinoma

Updated Category News Views 218

Regeneron Pharmaceuticals Secures Positive Opinion for Libtayo Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has made a significant stride in oncology with the recent endorsement from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP). They have issued a positive opinion for Libtayo (cemiplimab) as an adjuvant treatment to combat...

Continue Reading
Important Legal Update for Investors in Extreme Networks, Inc.

Updated Category News Views 131

Investor Warning: Key Deadline Approaching for Extreme Networks The Law Offices of Frank R. Cruz have a vital reminder for shareholders of Extreme Networks, Inc. As the deadline to file a lead plaintiff motion approaches, it is crucial that you stay informed about the details surrounding the class action lawsuit concerning the company. Understanding the Class Action This...

Continue Reading
The Rising Wave of Personal Watercraft Market Expansion

Updated Category News Views 79

Understanding the Personal Watercraft Market Surge As the enthusiasm for recreational water sports grows, the personal watercraft market is riding a wave of expansion. Recent projections indicate that the market will ascend from USD 2.7 billion in 2022 to an impressive USD 4.82 billion by 2032, with a robust compound annual growth rate (CAGR) of 6.0% during this period....

Continue Reading
Bybit Rethinks Crypto Security with AI Innovations

Updated Category News Views 185

Bybit Rethinks Crypto Security with AI Innovations Bybit is making impressive advancements in security protocols for its users by utilizing advanced artificial intelligence technologies. As one of the leading cryptocurrency exchanges worldwide, Bybit is dedicated to protecting its users' assets against increasingly sophisticated cyber threats. In a remarkable feat during...

Continue Reading
Exciting Nitro Circus and Dickies Partnership for Families

Updated Category News Views 242

An Exciting Partnership Between Nitro Circus and Genuine Dickies Nitro Circus, a pioneering force in action sports entertainment, has recently announced an innovative partnership with Genuine Dickies, a beloved workwear brand. The culmination of this partnership will be a thrilling 12-stop retailtainment tour taking place at select Walmart locations this summer. This tour...

Continue Reading